Synapse - Works

Results (71)

Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint blockade

Journal Article

Ged, Y.; Sanchez, A.; Patil, S.; Knezevic, A.; Stein, E.; Petruzella, S.; Weiss, K.; Duzgol, C.; Chaim, J.; Akin, O.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study

Meeting Abstract

Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
Cancer Research (2022)

Fulltext@MSK | Save

A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer

Journal Article

Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Comprehensive molecular characterization and response to therapy in fumarate hydratase-deficient renal cell carcinoma

Journal Article

Gleeson, J. P.; Nikolovski, I.; Dinatale, R.; Zucker, M.; Knezevic, A.; Patil, S.; Ged, Y.; Kotecha, R. R.; Shapnik, N.; Murray, S.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Pregnancy-associated breast cancer: Does timing of presentation affect outcome?

Meeting Abstract

Crown, A.; McCartan, D.; Curry, M.; Feldman, M.; Patil, S.; Kamer, S.; Goldfarb, S. B.; Gemignani, M.
Cancer Research (2021)

Fulltext@MSK | Save

Disparities in work status after treatment for breast cancer: A controlled, longitudinal study

Meeting Abstract

Blinder, V. S.; Patil, S.; Eberle, C.; Jung, G.; Kampel, L. J.; Hwang, C.; Bao, T.; Robson, M. E.; Malik, M.; Gany, F.
Cancer Epidemiology Biomarkers and Prevention (2020)

Fulltext@MSK | Save

Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer

Meeting Abstract

Traina, T. A.; Jones, L. W.; Blinder, V.; Scott, J.; Boyle, L. A.; Arumov, A.; Alano, T.; Patil, S.; DeFusco, P.; Lamparella, N.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Disease free survival rate with dose dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab (ddACTHP) in patients with HER2-positive early stage breast cancer: A single institution experience

Meeting Abstract

Singh, J. C.; Patil, S.; Norton, L.; Robson, M.; Dang, C.
Cancer Research (2020)

Fulltext@MSK | Save

A randomized phase 2 study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

Meeting Abstract

McArthur, H.; Comen, E.; Bryce, Y.; Solomon, S. B.; Leal, J.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D.; Norton, L.
Cancer Research (2020)

Fulltext@MSK | Save

A pilot randomized usual care controlled study of yoga for persistent chemotherapy-induced peripheral neuropathy (CIPN) in breast and gynecological cancer survivors

Meeting Abstract

Zhi, W. I.; Leeolou, M. C.; Piulson, L.; Chen, P.; Patterson, C.; Paul, T.; Patil, S.; Mao, J. J.; Bao, T.
Cancer Research (2019)

Fulltext@MSK | Save